BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khamesipour A, Amiri ZM, Kafiabad SA, Saadat F, Mansour-ghanaei F, Esteghamati AR, Shakib RJ. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran. Transfus Apher Sci 2011;45:195-7. [PMID: 21971311 DOI: 10.1016/j.transci.2011.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shirani K, Nokhodian Z, Kassaian N, Adibi P, Naeini AE, Ataei B. The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons. Adv Biomed Res 2015;4:17. [PMID: 25709982 DOI: 10.4103/2277-9175.148675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yao J, Ren W, Chen Y, Jiang Z, Shen L, Shan H, Dai X, Li J, Liu Y, Qiu Y, Ren J. Responses to hepatitis B vaccine in isolated anti-HBc positive adults. Hum Vaccin Immunother 2016;12:1847-51. [PMID: 27065099 DOI: 10.1080/21645515.2016.1139256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Virol J 2016;13:36. [PMID: 26944046 DOI: 10.1186/s12985-016-0492-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013;13:e6590. [PMID: 23675384 DOI: 10.5812/hepatmon.6590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
5 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
6 Mansour-Ghanaei F, Joukar F, Naghipour M, Hassanipour S, Yeganeh S, Sepehrimanesh M, Fathalipour M. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS). BMC Res Notes 2021;14:59. [PMID: 33568187 DOI: 10.1186/s13104-021-05474-2] [Reference Citation Analysis]
7 Homaie Rad E, Yazdi-Feyzabad V, Yousefzadeh-Chabok S, Afkar A, Naghibzadeh A. Pros and cons of the health transformation program in Iran: evidence from financial outcomes at the household level. Epidemiol Health 2017;39:e2017029. [PMID: 28728347 DOI: 10.4178/epih.e2017029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]